Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Advancing Regenerative Medicine with an Automated, Quality Controlled Cell Culturing System.


DURHAM, N.C. -- Tecan is collaborating with tissue engineering researchers at the University of Zurich History
The University of Zurich was founded in 1833 with existing colleges of theology (founded by Huldrych Zwingli in 1525), law and medicine merged together with a new faculty of Philosophy.
 to develop a novel, automated system for propagation of quality controlled cells that will be suitable for use in regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine therapies, such as intervertebral intervertebral /in·ter·ver·te·bral/ (-ver´te-bral) situated between two contiguous vertebrae; see under disk.

in·ter·ver·te·bral
adj.
Located between vertebrae.
 disc implants. The project is funded by the CTI (Computer Telephone Integration) Combining data with voice systems in order to enhance telephone services. For example, automatic number identification (ANI) allows a caller's records to be retrieved from the database while the call is routed to the appropriate party. , the Swiss Confederation's innovation promotion agency.

Tecan's new solution will control all necessary cell culture steps, including the isolation, seeding, proliferation, harvesting and analysis of cell lines and primary cells. Quality control will be maintained through two integrated detection devices that will determine the degree of cell confluence and detect the expression of cell type-specific genetic markers.

"I'm convinced that regenerative medicine through tissue engineering will become a clinical reality, but to reach our goals we urgently need automated cell culture systems focused on repeatability, robustness and data traceability," said Prof. Norbert Boos, Head of Spinal Surgery at the Orthopaedic University Hospital Balgrist, University of Zurich. "For example, cell-based nuclear replacement of the intervertebral disc seems a feasible and minimally invasive treatment for discogenic back pain, but the approach will not succeed without highly sensitized sensitized /sen·si·tized/ (sen´si-tizd) rendered sensitive.

sensitized

rendered sensitive.


sensitized cells
see sensitization (2).
, automated tissue culture. We are certain that Tecan has the know-how and the infrastructure to achieve our goals and we have had an excellent partnership so far."

The platform will be easily adjusted for culture of multiple cell types, providing standardized and affordable treatment procedures for regenerative medicine.

Research application, not for clinical diagnostic use.

About Tecan

Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP REMP Research, Engineering, Math and Physics (US NSA)  subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics See computer forensics.  laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere.  and Europe.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 12, 2008
Words:335
Previous Article:Hawaii Health Systems Corporation Extends Supply Chain Management Agreement with MedAssets to 2012.
Next Article:Willkie Enhances Litigation Department in Washington with Addition of Three Former SEC Officials.



Related Articles
Osiris Therapeutics and Cambrex subsidiary BioWhittaker form collaboration for adult stem cells.
Advanced Cell announces ruling on human applications of nuclear transfer, issuance of patent, and intent to appeal adverse ruling on animal claims.
Advanced Cell expands somatic cell nuclear transfer cellular reprogramming intellectual property portfolio.
BREAST RECONSTRUCTION STUDY INITIATED IN JAPAN.
Olympus Expands Investment, Partnership with Cytori Therapeutics in Regenerative Medecine.
StemCor systems announces acquisition of intellectual property to enhance bone marrow aspiration platform.
Non-surgical stem-cell procedure relieves degenerative joint disease.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles